1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Ye, J.
Mayer, K.L.
Mayer, M.R.
Stone, M.J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
40
7820
7831
10.1021/bi010252s
11425309
NMR solution structure and backbone dynamics of the CC chemokine eotaxin-3.
2001
10.2210/pdb1g2s/pdb
pdb_00001g2s
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
8412.857
EOTAXIN-3
1
man
polymer
SMALL INDUCIBLE CYTOKINE A26, MACROPHAGE INFLAMMATORY PROTEIN 4-ALPHA
no
no
TRGSDISKTCCFQYSHKPLPWTWVRSYEFTSNSCSQRAVIFTTKRGKKVCTHPRKKWVQKYISLLKTPKQL
TRGSDISKTCCFQYSHKPLPWTWVRSYEFTSNSCSQRAVIFTTKRGKKVCTHPRKKWVQKYISLLKTPKQL
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
Escherichia coli
sample
EOTAXIN-3
9606
LUNG
Homo sapiens
469008
Escherichia coli BL21(DE3)
BL21(DE3)
PLASMID
PET28A+
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2002-03-13
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
Solution Structure of Eotaxin-3, Ensemble of 20 structures
RCSB
Y
RCSB
2000-10-20
REL
REL
1
3D_15N-separated_NOESY
HNHA
15N, 13C simultaneously edited NOESY
3D_13C-separated_NOESY
13C-edited HSQC
20 mM
5
ambient
303
K
The structures are based on a total of 1250 restraints, 1157 are NOE-derived distance constraints, 69 dihedral angle restraints, 17 distance restraints from hydrogen bonds.
distance geometry-simulated annealing protocol implemented in XPLOR
minimized average structure
2 mM eotaxin-3,U-15N, 20mM sodium acetate (deteurated), 90% H2O, 10% D2O
90% H2O/10% D2O
2 mM eotaxin-3,U-15N, 13C, 20mM sodium acetate (deteurated), 90% H2O, 10% D2O
90% H2O/10% D2O
2 mM eotaxin-3,U-15N, 13C, 20mM sodium acetate (deteurated), 100% D2O
100% D2O
0.5 mM eotaxin-3,10% 13C-labeled, 20mM sodium acetate (deteurated), 100% D2O
100% D2O
Brunger
structure solution
X-PLOR
XPLOR98.1
msi industry
data analysis
Felix
felix98
Varian
collection
VNMR
VNMR6.1
Laskowski
structure solution
Procheck_nmr
PROCHECK v.3
Laskowski
refinement
Procheck_nmr
PROCHECK v.3
500
Varian
UNITY
THR
1
n
1
THR
1
A
ARG
2
n
2
ARG
2
A
GLY
3
n
3
GLY
3
A
SER
4
n
4
SER
4
A
ASP
5
n
5
ASP
5
A
ILE
6
n
6
ILE
6
A
SER
7
n
7
SER
7
A
LYS
8
n
8
LYS
8
A
THR
9
n
9
THR
9
A
CYS
10
n
10
CYS
10
A
CYS
11
n
11
CYS
11
A
PHE
12
n
12
PHE
12
A
GLN
13
n
13
GLN
13
A
TYR
14
n
14
TYR
14
A
SER
15
n
15
SER
15
A
HIS
16
n
16
HIS
16
A
LYS
17
n
17
LYS
17
A
PRO
18
n
18
PRO
18
A
LEU
19
n
19
LEU
19
A
PRO
20
n
20
PRO
20
A
TRP
21
n
21
TRP
21
A
THR
22
n
22
THR
22
A
TRP
23
n
23
TRP
23
A
VAL
24
n
24
VAL
24
A
ARG
25
n
25
ARG
25
A
SER
26
n
26
SER
26
A
TYR
27
n
27
TYR
27
A
GLU
28
n
28
GLU
28
A
PHE
29
n
29
PHE
29
A
THR
30
n
30
THR
30
A
SER
31
n
31
SER
31
A
ASN
32
n
32
ASN
32
A
SER
33
n
33
SER
33
A
CYS
34
n
34
CYS
34
A
SER
35
n
35
SER
35
A
GLN
36
n
36
GLN
36
A
ARG
37
n
37
ARG
37
A
ALA
38
n
38
ALA
38
A
VAL
39
n
39
VAL
39
A
ILE
40
n
40
ILE
40
A
PHE
41
n
41
PHE
41
A
THR
42
n
42
THR
42
A
THR
43
n
43
THR
43
A
LYS
44
n
44
LYS
44
A
ARG
45
n
45
ARG
45
A
GLY
46
n
46
GLY
46
A
LYS
47
n
47
LYS
47
A
LYS
48
n
48
LYS
48
A
VAL
49
n
49
VAL
49
A
CYS
50
n
50
CYS
50
A
THR
51
n
51
THR
51
A
HIS
52
n
52
HIS
52
A
PRO
53
n
53
PRO
53
A
ARG
54
n
54
ARG
54
A
LYS
55
n
55
LYS
55
A
LYS
56
n
56
LYS
56
A
TRP
57
n
57
TRP
57
A
VAL
58
n
58
VAL
58
A
GLN
59
n
59
GLN
59
A
LYS
60
n
60
LYS
60
A
TYR
61
n
61
TYR
61
A
ILE
62
n
62
ILE
62
A
SER
63
n
63
SER
63
A
LEU
64
n
64
LEU
64
A
LEU
65
n
65
LEU
65
A
LYS
66
n
66
LYS
66
A
THR
67
n
67
THR
67
A
PRO
68
n
68
PRO
68
A
LYS
69
n
69
LYS
69
A
GLN
70
n
70
GLN
70
A
LEU
71
n
71
LEU
71
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
GLU
28
A
N
GLU
28
A
O
ILE
40
A
O
ILE
40
A
N
PHE
41
A
N
PHE
41
A
O
VAL
49
A
O
VAL
49
1
A
ARG
2
0.292
SIDE CHAIN
1
A
ARG
25
0.246
SIDE CHAIN
1
A
ARG
37
0.316
SIDE CHAIN
1
A
ARG
45
0.220
SIDE CHAIN
1
A
ARG
54
0.272
SIDE CHAIN
1
A
ILE
6
-93.14
39.42
1
A
SER
7
-95.84
41.24
1
A
PHE
12
-160.11
-64.05
1
A
HIS
16
-114.77
74.83
1
A
ARG
25
-124.40
-61.33
1
A
SER
26
-153.54
-153.46
1
A
GLU
28
-177.38
137.86
1
A
LYS
66
-174.39
141.84
1
A
LYS
69
-115.89
52.90
minimized average
SOLUTION STRUCTURE OF EOTAXIN-3
1
N
N
A
PRO
20
A
PRO
20
HELX_P
A
THR
22
A
THR
22
5
1
3
A
LYS
55
A
LYS
55
HELX_P
A
LYS
66
A
LYS
66
1
2
12
disulf
2.021
A
CYS
10
A
SG
CYS
10
1_555
A
CYS
34
A
SG
CYS
34
1_555
disulf
2.021
A
CYS
11
A
SG
CYS
11
1_555
A
CYS
50
A
SG
CYS
50
1_555
CYTOKINE
beta-beta-beta-alpha helix, CYTOKINE
CCL26_HUMAN
UNP
1
1
Q9Y258
MMGLSLASAVLLASLLSLHLGTATRGSDISKTCCFQYSHKPLPWTWVRSYEFTSNSCSQRAVIFTTKRGKKVCTHPRKKW
VQKYISLLKTPKQL
24
94
1G2S
1
71
Q9Y258
A
1
1
71
3
anti-parallel
anti-parallel
A
VAL
24
A
VAL
24
A
PHE
29
A
PHE
29
A
VAL
39
A
VAL
39
A
THR
43
A
THR
43
A
LYS
48
A
LYS
48
A
THR
51
A
THR
51